NHIQ: AI 评分 52/100 — AI 分析 (4月 2026)

NantHealth, Inc. operates as a healthcare IT company, providing software and data solutions. Their focus is on streamlining communication and information access for payers and providers, particularly in cancer care.

Key Facts: AI Score: 52/100 Sector: Healthcare

公司概况

概要：

NantHealth, Inc. delivers SaaS-based clinical decision support and data solutions to healthcare providers and payers, focusing on oncology and network monitoring. Their Eviti platform and NaviNet solutions aim to improve care coordination and streamline administrative processes within the complex healthcare ecosystem, operating primarily in the US, Canada, and the UK.

NHIQ是做什么的？

NantHealth, Inc., established in 2010 and headquartered in Morrisville, North Carolina, is a healthcare IT company operating in the United States, Canada, and the United Kingdom. As a subsidiary of NantWorks, LLC, NantHealth provides a suite of software and data solutions designed to improve healthcare delivery and administrative efficiency. The company's core offerings include the Eviti platform, a SaaS-based clinical decision support system that centralizes clinical content, treatment cost data from Medicare reimbursements, and treatment toxicity data. Eviti Connect leverages this platform to automate pre-authorization processes, assisting payers and providers in navigating the complexities of cancer care. Additionally, Eviti Advisor allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. NantHealth also offers NaviNet, a suite of SaaS-based solutions that streamline communication and consolidate information between payers and providers. NaviNet Open serves as a payer-provider collaboration platform, while NaviNet AllPayer provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, including Medicare beneficiaries. Furthermore, NantHealth provides OpenNMS, an open-source network monitoring solution for enterprise-grade networks, and Quadris, a data solution that includes multi-data analysis, reporting, and professional services. Originally known as Nant Health, LLC, the company changed its name to NantHealth, Inc. in June 2016.

NHIQ的投资论点是什么？

NantHealth, Inc. operates in the healthcare IT sector, which is experiencing growth due to the increasing need for efficient data management and care coordination. The company's Eviti platform and NaviNet solutions address these needs, particularly in the oncology space. However, with a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance raises concerns. A gross margin of 57.0% indicates some operational efficiency, but a profit margin of -101.2% suggests significant challenges in achieving profitability. Key value drivers include expanding the adoption of Eviti and NaviNet solutions, securing new partnerships with payers and providers, and demonstrating improved financial performance. The high beta of -5.74 suggests high volatility. Investors should carefully consider the company's financial stability and growth prospects before investing.

NHIQ在哪个行业运营？

NantHealth, Inc. operates within the healthcare IT sector, a market driven by the increasing adoption of electronic health records (EHRs), the growing need for interoperability, and the rising demand for data analytics solutions. The industry is characterized by intense competition, with established players like ACHKF (Allscripts Healthcare Solutions) and ALDNF (Cerner Corporation) vying for market share. NantHealth's focus on oncology and payer-provider communication positions it within specific niches of this broader market. The healthcare IT market is projected to continue growing, fueled by government initiatives promoting healthcare digitization and the increasing prevalence of chronic diseases.

Medical - Healthcare Information Services

Healthcare

NHIQ有哪些增长机遇？

Expansion of Eviti Platform: NantHealth has the opportunity to expand the capabilities of its Eviti platform to cover a broader range of cancer types and treatment modalities. By incorporating the latest research and clinical guidelines, Eviti can become an even more valuable tool for oncologists, driving increased adoption and revenue growth. The market for oncology clinical decision support systems is projected to reach $1.5 billion by 2028, presenting a significant opportunity for NantHealth to capture a larger share.
Strategic Partnerships with Payers: Collaborating with major health insurance companies to integrate NaviNet into their existing systems can streamline pre-authorization processes and improve communication with providers. This can lead to increased efficiency and cost savings for payers, making NaviNet an attractive solution. The market for payer-provider communication platforms is estimated at $2.2 billion, offering substantial growth potential for NantHealth through strategic partnerships.
Geographic Expansion into Europe: Expanding its operations into European markets, where healthcare systems are increasingly focused on digitization and value-based care, represents a significant growth opportunity for NantHealth. By adapting its Eviti and NaviNet solutions to meet the specific needs of European healthcare providers and payers, NantHealth can tap into a new revenue stream. The European healthcare IT market is projected to reach $80 billion by 2027.
Development of AI-Powered Analytics: Incorporating artificial intelligence (AI) and machine learning (ML) into its Quadris data solution can enable NantHealth to provide more advanced analytics and insights to healthcare providers and payers. This can help them identify trends, predict outcomes, and optimize treatment strategies. The market for AI in healthcare is projected to reach $45 billion by 2026, presenting a significant opportunity for NantHealth to leverage its data assets and expertise.
Integration with Telehealth Platforms: Integrating its Eviti and NaviNet solutions with telehealth platforms can enable NantHealth to extend its reach and provide its services to a wider range of patients and providers. This can be particularly valuable in rural areas and underserved communities, where access to specialized healthcare services may be limited. The telehealth market is projected to reach $175 billion by 2026, offering a substantial growth opportunity for NantHealth through strategic integrations.

Market Cap of $0.00B indicates a micro-cap company with high growth potential but also higher risk.
Gross Margin of 57.0% demonstrates the potential for profitability if operating expenses are managed effectively.
Profit Margin of -101.2% signals significant challenges in achieving profitability and requires close monitoring.
Beta of -5.74 suggests the stock price moves inversely and more drastically than the market, indicating high volatility.
Offers SaaS based solutions - clinical decision support and network monitoring - which can lead to recurring revenue streams.

NHIQ提供哪些产品和服务？

Offers Eviti, a SaaS-based clinical decision support solution for cancer treatment.
Provides Eviti Connect, automating pre-authorization for cancer care.
Offers Eviti Advisor, giving physicians access to evidence-based treatment standards.
Delivers NaviNet, a suite of SaaS solutions for payer-provider communication.
Provides NaviNet Open, a platform for collaboration between health plans and providers.
Offers NaviNet AllPayer, providing eligibility and claim status information.
Provides OpenNMS, an open-source network monitoring solution.
Offers Quadris, a data solution for multi-data analysis and reporting.

NHIQ如何赚钱？

Software-as-a-Service (SaaS): Generates recurring revenue through subscriptions to its Eviti and NaviNet platforms.
Data Solutions: Provides data analysis, reporting, and professional services through its Quadris solution.
Platform Integration: Earns revenue by integrating its solutions with payer and provider systems.

Healthcare Providers: Oncologists, hospitals, and clinics use Eviti to support treatment decisions.
Health Insurance Companies: Payers use NaviNet to streamline communication and pre-authorization processes.
Enterprise-Grade Networks: Organizations use OpenNMS for network monitoring.

Proprietary Technology: Eviti's comprehensive library of evidence-based treatment standards and protocols provides a competitive advantage.
Established Relationships: Long-standing relationships with payers and providers create switching costs.
Data Network Effects: The more users on the NaviNet platform, the more valuable it becomes for all participants.

什么因素可能推动NHIQ股价上涨？

Ongoing: Expansion of the Eviti platform to cover additional cancer types and treatment modalities.
Ongoing: Strategic partnerships with major health insurance companies to integrate NaviNet.
Upcoming: Potential geographic expansion into European markets.
Upcoming: Development and launch of AI-powered analytics for the Quadris data solution.
Ongoing: Integration of Eviti and NaviNet solutions with telehealth platforms.

NHIQ的主要风险是什么？

Ongoing: Intense competition from larger healthcare IT companies.
Potential: Changes in healthcare regulations and reimbursement policies.
Potential: Data security and privacy concerns.
Potential: Technological obsolescence.
Ongoing: Negative profit margin and financial challenges.

NHIQ的核心优势是什么？

Comprehensive Eviti platform for cancer treatment decision support.
NaviNet platform for streamlined payer-provider communication.
SaaS-based business model providing recurring revenue.
Established presence in the US, Canada, and the UK.

NHIQ的劣势是什么？

Negative profit margin indicating financial challenges.
High beta suggesting high stock price volatility.
Limited market capitalization compared to larger competitors.
Dependence on NantWorks, LLC for resources and support.

NHIQ有哪些机遇？

Expansion of Eviti platform to cover more cancer types.
Strategic partnerships with major health insurance companies.
Geographic expansion into European markets.
Development of AI-powered analytics for Quadris data solution.

NHIQ面临哪些威胁？

Intense competition from larger healthcare IT companies.
Changes in healthcare regulations and reimbursement policies.
Data security and privacy concerns.
Potential for technological obsolescence.

NHIQ的竞争对手是谁？

Allscripts Healthcare Solutions — Offers a broad range of healthcare IT solutions, including EHRs and practice management systems. — (ACHKF)
Cerner Corporation — Provides EHRs and healthcare information technology solutions. — (ALDNF)
Allsec Technologies — Offers business process solutions, including healthcare-related services. — (ALSE)
Anthem — Health benefits company offering a range of insurance products. — (AQQRF)
Humana — Health insurance company providing a variety of healthcare plans. — (HURA)

Key Metrics

MoonshotScore: 52/100

Company Profile

CEO: Rao Haris Naseem FACC,
Headquarters: Morrisville, US
Employees: 365
Founded: 2016

AI Insight

AI analysis pending for NHIQ

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does NantHealth, Inc. do?

NantHealth, Inc. operates as a healthcare IT company, providing software and data solutions designed to improve healthcare delivery and administrative efficiency. Its core offerings include the Eviti platform, a SaaS-based clinical decision support system for cancer treatment, and the NaviNet platform, which streamlines communication and information exchange between payers and providers. The company also offers network monitoring solutions and data analytics services, targeting healthcare providers, health insurance companies, and enterprise-grade networks. NantHealth aims to enhance care coordination, reduce costs, and improve patient outcomes through its technology solutions.

What do analysts say about NHIQ stock?

AI analysis is currently pending for NHIQ. However, considering the company's financials, including a $0.00B market cap, negative P/E ratio, and a profit margin of -101.2%, analysts would likely focus on the company's ability to improve its financial performance and achieve profitability. Key valuation metrics to watch include revenue growth, gross margin, and operating expenses. Growth considerations would likely center on the company's ability to expand its Eviti and NaviNet platforms, secure new partnerships, and penetrate new markets. The high beta of -5.74 also suggests high volatility, which analysts would consider.

What are the main risks for NHIQ?

NantHealth, Inc. faces several risks, including intense competition from larger healthcare IT companies, potential changes in healthcare regulations and reimbursement policies, and data security and privacy concerns. The company's negative profit margin and financial challenges also pose a significant risk. Additionally, the company faces the risk of technological obsolescence, as the healthcare IT industry is rapidly evolving. As an OTC stock, NHIQ faces additional risks related to liquidity, information scarcity, and price volatility. These risks could negatively impact the company's financial performance and market value.